Cholesterol absorption and lipoprotein metabolism in type II diabetes mellitus with and without coronary artery disease


      Hypercholesterolemia is an important atherogenic risk factor in type II diabetes, and although coronary artery disease (CAD) is frequent in these patients, it is not known whether cholesterol and lipoprotein metabolism differ in patients with (CAD +) and without CAD (CAD −). Our aim was to study cholesterol metabolism and lipoprotein kinetics in mildly hypercholesterolemic type II diabetic men with and without CAD under similar dietary conditions. Despite similar serum and lipoprotein cholesterol levels, and kinetics of total and dense LDL apo B, light and dense LDL particles were cholesterol-enriched only in CAD + subjects. Apolipoprotein A-II level was lower in CAD + than in CAD − subjects (27.1 ± 0.7 versus 30.9 ± 0.7 mg/dl, P < 0.05), HDL cholesterol and apolipoprotein A-I kinetics were similar in the two groups. Cholesterol absorption was significantly higher in the CAD + versus CAD − subjects (27 ± 2 versus 20 ± 3%, P < 0.05). In multiple logistic stepwise regression analysis with CAD as the dependent variable, cholesterol absorption efficiency and serum plant sterol/cholesterol proportions were the only variables significantly associated with CAD. In conclusion, in mildly hypercholesterolemic type II diabetic patients, the only metabolic parameter differentiating CAD patients from non-CAD ones was significantly higher cholesterol absorption efficiency in the coronary patients, which could contribute to the finding of the atherogenic cholesterol-rich dense LDL subfraction in these patients. Thus, a treatment causing cholesterol malabsorption by sitostanol alone or in combination with statin could be beneficial in these patients.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kannel WB
        • McGee DL
        Diabetes and cardiovascular risk factors: the Framingham study.
        Circulation. 1979; 59: 8-13
      1. Stamler J, Wentworth D, Neaton J, Schoenberger JA, Feigal D for the MRFIT Research Group. Diabetes and risk of coronary, cardiovascular, and all causes mortality: findings for 356 000 men screened by the Multiple Risk Factor Intervention Trial (MRFIT). Circulation 1984;70(suppl 2):II-161.

        • Hanefeld M
        • Schmechel H
        • Julius U
        • et al.
        • DIS Group
        Five-year incidence of coronary heart disease related to major risk factors and metabolic control in newly diagnosed non-insulin-dependent diabetes.
        Nutr Metab Cardiovasc Dis. 1991; 1: 135-140
        • Uusitupa MIJ
        • Niskanen LK
        • Siitonen O
        • Voutilainen E
        • Pyörälä K
        5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.
        Circulation. 1990; 82: 27-36
        • Fontbonne AM
        • Eschwege EM
        Insulin and cardiovascular disease. Paris Prospective Study.
        Diabetes Care. 1991; 14: 461-469
        • Stern MP
        • Haffner SM
        Dyslipidemia in type II diabetes. Implications for therapeutic intervention.
        Diabetes Care. 1991; 14: 1144-1159
        • Ginsberg HN
        Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
        Diabetes Care. 1991; 14: 839-855
        • Reaven GM
        Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis.
        Metabolism. 1987; 36: 1-8
        • Schonfeld G
        • Birge C
        • Miller JP
        • Kessler G
        • Santiago J
        Apolipoprotein B levels and altered lipoprotein composition in diabetes.
        Diabetes. 1974; 23: 827-834
        • Iwai M
        • Yoshino G
        • Matsushita M
        • et al.
        Abnormal lipoprotein composition in normolipidemic diabetic patients.
        Diabetes Care. 1990; 13: 792-796
        • Stewart MW
        • Laker MF
        • Dyer RG
        • et al.
        Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia.
        Arterioscler Thromb. 1993; 13: 1046-1052
        • Feingold KR
        • Grunfeld C
        • Pang M
        • Doerrler W
        • Krauss RM
        LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes.
        Arterioscler Thromb. 1992; 12: 1496-1502
        • Austin MA
        • Breslow JL
        • Hennekens CH
        • Buring JE
        • Willett WC
        • Krauss RM
        Low density lipoprotein sub-class patterns and risk of myocardial infarction.
        J Am Med Assoc. 1988; 260: 1917-1921
        • Hiramatsu K
        • Arimori S
        Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes.
        Diabetes. 1988; 37: 832-837
        • Lopes-Virella MF
        • Klein RL
        • Lyons TJ
        • Stevenson HC
        • Witztum JL
        Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocytederived macrophages.
        Diabetes. 1988; 37: 550-557
        • Steinbrecher UP
        • Witztum JL
        Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism.
        Diabetes. 1984; 33: 130-134
        • Miettinen TA
        Cholesterol metabolism in patients with coronary heart disease.
        Ann Clin Res. 1971; 3: 313-322
        • Simonen H
        • Miettinen TA
        Coronary artery disease and bile acid synthesis in familial hypercholesterolemia.
        Atherosclerosis. 1987; 63: 159-166
        • Kesäniemi YA
        • Grundy SM
        Overproduction of low density lipoproteins associated with coronary heart disease.
        Arteriosclerosis. 1983; 3: 40-46
      2. Knuts L-R, Rastas M, Haapala P. Micro-Nutrica. Version 1.0. Helsinki:Kansaneläkelaitos, 1991.

        • Bolin DW
        • King RP
        • Klosterman EW
        A simplified method for the determination of chromic oxide (Cr2O3) when used as an index substance.
        Science. 1952; 116: 634-635
        • Crouse JR
        • Grundy SM
        Evaluation of a continuous isotope feeding method for measurement of cholesterol absorption in man.
        J Lipid Res. 1978; 19: 967-971
        • Miettinen TA
        Gas-liquid chromatographic determination of fecal neutral sterols using a capillary column.
        Clin Chim Acta. 1982; 124: 245-248
        • Miettinen TA
        • Ahrens Jr, EH
        • Grundy SM
        Quantitative isolation and gas-liquid chromatographic analysis of total dietary and fecal neutral steroids.
        J Lipid Res. 1965; 6: 411-424
        • Grundy SM
        • Ahrens Jr, EH
        • Miettinen TA
        Quantitative isolation and gas-liquid chromatographic analysis of total fecal bile acids.
        J Lipid Res. 1965; 6: 397-410
      3. Lipid and Lipoprotein Analysis. Manual of Laboratory Operations, Lipid Research Clinic Program. Washington D.C.: DHEW Publication No NIH/75-628. 1974:63–70.

        • Gylling H
        • Vanhanen H
        • Miettinen TA
        Effects of ketoconazole on cholesterol precursors and low density lipoprotein kinetics in hypercholesterolemia.
        J Lipid Res. 1993; 34: 59-67
        • Havekes LM
        • de Knijff P
        • Beisiegel U
        • Havinga J
        • Smit M
        • Klasen E
        A rapid micromethod for apolipoprotein E phenotyping directly in serum.
        J Lipid Res. 1987; 28: 445-463
        • Catignoni GL
        • Bieri JG
        Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography.
        Clin Chem. 1983; 29: 708-712
        • Vega GL
        • Gylling H
        • Nichols AV
        • Grundy SM
        Evaluation of a method for study of kinetics of autologous apolipoprotein A-I.
        J Lipid Res. 1991; 32: 867-875
        • McFarlane AS
        Efficient trace-labeling of proteins with iodine.
        Nature. 1958; 182: 53
        • Bilheimer DW
        • Eisenberg S
        • Levy RI
        The metabolism of very low density lipoproteins..
        Biochim Biophys Acta. 1972; 260: 212-221
        • Gylling H
        • Miettinen TA
        Non-cholesterol sterols, absorption and synthesis of cholesterol and apolipoprotein A-I kinetics in a Finnish lecithin-cholesterol acyltransferase deficient family.
        Atherosclerosis. 1992; 95: 25-33
        • Matthews CME
        The theory of tracer experiments with [131I]-labeled plasma proteins.
        Phys Med Biol. 1957; 2: 36-53
        • Miettinen TA
        • Tilvis RS
        • Kesäniemi YA
        Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population.
        Am J Epidemiol. 1990; 131: 20-31
        • Kesäniemi YA
        • Ehnholm C
        • Miettinen TA
        Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype.
        J Clin Invest. 1987; 80: 578-581
        • Gertler MM
        • Woodbury MA
        • Gottsch LG
        • White PD
        • Rusk HA
        The candidate for coronary heart disease — discriminating power of biochemical hereditary and anthropometric measurements.
        J Am Med Assoc. 1959; 170: 149-152
        • Miettinen TA
        • Lampainen E
        • Penttilä IM
        Familial occurrence of mild hyperlipoproteinaemias.
        Clin Genet. 1972; 3: 271-280
        • Miettinen TA
        • Aro A
        Faecal fat, bile acid excretion, and body height in familial hypercholesterolaemia and hyperglyceridaemia.
        Scand J Clin Lab Invest. 1972; 30: 85-88
        • Zanni EE
        • Zannis VI
        • Blum CB
        • Herbert PN
        • Breslow JL
        Effect of egg cholesterol and dietary fats on plasma lipids, lipoproteins, and apoproteins of normal women consuming natural diets.
        J Lipid Res. 1987; 28: 518-527
        • Miettinen TA
        • Kesäniemi YA
        Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels.
        Am J Clin Nutr. 1989; 49: 629-635
        • Quintao E
        • Grundy SM
        • Ahrens Jr, EH
        Effects of dietary cholesterol on the regulation of total body cholesterol in man.
        J Lipid Res. 1971; 12: 233-247
        • Shekelle RB
        • Stamler J
        Dietary cholesterol and ischaemic heart disease.
        Lancet. 1989; I: 1177-1179
      4. Miettinen TA, Strandberg T, Vanhanen H, Gylling H, for the 4S Group. Non-cholesterol serum sterols in Scandinavian Simvastatin Survival Study. XII International Symposium on Drugs Affecting Lipid Metabolism, November 7–10, 1995 Houston Texas. Abstracts, p. 34.

        • Gylling H
        • Miettinen TA
        Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment.
        Diabetologia. 1994; 37: 773-780